sodium hydrogencarbonate/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases systolic blood pressure (setting unspecified)
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“However, higher risk of elevated systolic BP was found with sodium bicarbonate treatment (SMD, 0.10; 95% CI, 0.01 to 0.20; P = 0.03).”
Quoted verbatim from Sodium Bicarbonate Treatment and Clinical Outcomes in Chronic Kidney Disease with Metabolic Acidosis: A Meta-Analysis.. - Study
- meta-analysis
- Population
- Patients with chronic kidney disease and metabolic acidosis in randomized controlled trials; control groups defined inconsistently across trials
Effect 0.1 standardised mean difference, 95% CI 0.01 to 0.2
Sodium Bicarbonate Treatment and Clinical Outcomes in Chronic Kidney Disease with Metabolic Acidosis: A Meta-Analysis.2024PMID:38980732Permalink
Keep reading
- Everything the graph holds on sodium hydrogencarbonate
- Every compound studied against Systolic blood pressure (setting unspecified)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PPSZVVABRXQJMPXCP59VGN